Literature DB >> 29953878

Metabolic and Bariatric Surgery: An Effective Treatment Option for Obesity and Cardiovascular Disease.

Wayne J English1, D Brandon Williams2.   

Abstract

Obesity is a chronic and debilitating disease that has become a global epidemic. Especially severe in the Unites States, obesity currently affects almost 40% of the population. Obesity has a strong causal relationship with numerous serious comorbidities that impair quality of life, shorten life expectancy, and carry a major economic burden. Obesity has particular relevance to cardiologists because it contributes directly to several major cardiovascular diseases and, consequently, increases overall cardiovascular mortality. Multiple treatment options are available, but metabolic and bariatric surgery offers the most effective and durable treatment for obesity. Moreover, metabolic and bariatric operations alleviate and often completely eliminate numerous comorbidities, particularly type 2 diabetes and other cardiovascular risk factors, such as hypertension and dyslipidemia. With their low risk of complications and morbidity, metabolic and bariatric operations significantly improve quality of life and overall survival, particularly reducing death due to cardiovascular disease.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Bariatric surgery complications; Bariatric surgery outcomes; Bariatric surgery safety; Cardiometabolic disease; Cardiovascular disease; Diabetes mellitus; Metabolic and bariatric surgery; Obesity

Mesh:

Year:  2018        PMID: 29953878     DOI: 10.1016/j.pcad.2018.06.003

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  9 in total

Review 1.  Meal patterns after bariatric surgery in mice and rats.

Authors:  Harsh Shah; Andrew C Shin
Journal:  Appetite       Date:  2019-06-29       Impact factor: 3.868

2.  The characterization of metabolites alterations in white adipose tissue of diabetic GK Rats after ileal transposition surgery by an untargeted metabolomics approach.

Authors:  Xiaorui Lyu; Kemin Yan; Weijie Chen; Yujie Wang; Huijuan Zhu; Hui Pan; Guole Lin; Linjie Wang; Hongbo Yang; Fengying Gong
Journal:  Adipocyte       Date:  2021-12       Impact factor: 4.534

3.  Adenovirus 36 prevalence and association with human obesity: a systematic review.

Authors:  Jaime da Silva Fernandes; Fabiana Schuelter-Trevisol; Ana Carolina Lobor Cancelier; Helena Caetano Gonçalves E Silva; Daiana Gomes de Sousa; Richard L Atkinson; Daisson José Trevisol
Journal:  Int J Obes (Lond)       Date:  2021-03-22       Impact factor: 5.095

4.  LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.

Authors:  Tamer Coskun; Kyle W Sloop; Corina Loghin; Jorge Alsina-Fernandez; Shweta Urva; Krister B Bokvist; Xuewei Cui; Daniel A Briere; Over Cabrera; William C Roell; Uma Kuchibhotla; Julie S Moyers; Charles T Benson; Ruth E Gimeno; David A D'Alessio; Axel Haupt
Journal:  Mol Metab       Date:  2018-10-03       Impact factor: 7.422

Review 5.  Cardiovascular Effects of Metabolic Surgery on Type 2 Diabetes.

Authors:  Christos Damaskos; Alexandros Litos; Dimitrios Dimitroulis; Efstathios A Antoniou; Dimitrios Mantas; Konstantinos Kontzoglou; Nikolaos Garmpis
Journal:  Curr Cardiol Rev       Date:  2020

6.  Renoprotective role of bariatric surgery in patients with established chronic kidney disease.

Authors:  Enrique Morales; Esteban Porrini; Marina Martin-Taboada; Sergio Luis-Lima; Rocío Vila-Bedmar; Ignacio González de Pablos; Pilar Gómez; Elías Rodríguez; Lucia Torres; Borja Lanzón; Ana Elena Rodríguez; María Maíz; Gema Medina-Gómez; Manuel Praga
Journal:  Clin Kidney J       Date:  2020-12-23

Review 7.  Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms.

Authors:  Yu Ji; Hangil Lee; Shawn Kaura; James Yip; Hao Sun; Longfei Guan; Wei Han; Yuchuan Ding
Journal:  Biomolecules       Date:  2021-10-26

8.  A Hub and Spoke Learning Program in Bariatric Surgery in a Small Region of Italy.

Authors:  Antonio Buondonno; Pasquale Avella; Micaela Cappuccio; Andrea Scacchi; Roberto Vaschetti; Giancarlo Di Marzo; Pietro Maida; Claudio Luciani; Bruno Amato; Maria Chiara Brunese; Daniela Esposito; Lucio Selvaggi; Germano Guerra; Aldo Rocca
Journal:  Front Surg       Date:  2022-03-24

9.  Predictors of normalized HbA1c after gastric bypass surgery in subjects with abnormal glucose levels, a 2-year follow-up study.

Authors:  Neda Rajamand Ekberg; Henrik Falhammar; Erik Näslund; Kerstin Brismar
Journal:  Sci Rep       Date:  2020-09-15       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.